Preview Mode Links will not work in preview mode

Psychopharmacology and Psychiatry Updates

Sep 29, 2021

Delirium has been frequently found in patients who test positive for COVID-19. It has additional features that we do not typically see in ordinary delirium. The critical question is: How do you manage these patients?

Guest: Scott Beach, M.D.
Interviewer: Wegdan Rashad, M.D.
Hosts: Jessica Diaz, M.D.; Flavio Guzman,...

Sep 24, 2021

This episode discusses the assessment of adherence: Self-report, electronic medication monitoring systems, rating scales, medication possession ratio, questions for assessing medication adherence, and the recommended frequency of adherence monitoring. 

Faculty: Martha Sajatovic, M.D.
Hosts: Jessica Diaz, M.D.; Flavio...

Sep 19, 2021

A new randomized trial suggests that the efficacy of antidepressants for the treatment of bipolar depression is no greater than placebo. This tips the meta-analytic balance scale, which already pointed in this direction.

Faculty: Jim Phelps, M.D.
Hosts: Jessica Diaz, M.D.; Flavio Guzman, M.D.

Sep 14, 2021

This podcast offers a discussion on catatonia and delirium as well as treatments for their co-occurrence. Treatments discussed include benzodiazepines, amantadine, and memantine. We also address the management of COVID-19 delirium with antipsychotics.

Faculty: Scott Beach, M.D.
Hosts: Jessica Diaz, M.D.; Flavio Guzman,...

Sep 9, 2021

Is psilocybin a potential treatment for major depression? There's certainly been a lot of press coverage, but to date, the reports are largely open trials in a variety of conditions, including OCD, substance use, PTSD, and patients with cancer and psychological distress. Against that backdrop, a randomized trial of...